1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Hunting down the cause of ME/CFS & other challenging disorders - Lipkin in London
In a talk to patients in London on 3rd September, Dr. W. Ian Lipkin described the extraordinary lengths he and his team are prepared to go to in order to track down the source of an illness, with examples ranging from autism to the strange case of Kawasaki disease.
Discuss the article on the Forums.

Viral Biofilms

Discussion in 'Other Health News and Research' started by me_is_realist, Jan 19, 2011.

  1. me_is_realist

    me_is_realist

    Messages:
    28
    Likes:
    3
    ScienceDaily (Feb. 8, 2010) Researchers at the Institut Pasteur and CNRS have shown for the first time that certain viruses are capable of forming complex biofilm-like assemblies, similar to bacterial biofilms. These extracellular infectious structures may protect viruses from the immune system and enable them to spread efficiently from cell to cell. "Viral biofilms" would appear to be a major mechanism of propagation for certain viruses. They are therefore emerging as new and particularly attractive therapeutic targets.
    See Also:
    Health & Medicine

    * Viruses
    * Infectious Diseases
    * HIV and AIDS

    Plants & Animals

    * Virology
    * Bacteria
    * Microbes and More

    Reference

    * Human parainfluenza viruses
    * Natural killer cell
    * Hepatitis B
    * Vector (biology)

    Researchers from the Institut Pasteur and CNRS, headed by Maria-Isabel Thoulouze and Andrs Alcover within the Lymphocyte Cell Biology Unit, in collaboration with Antoine Gessain from the Oncogenic Virus Epidemiology and Physiopathology Unit and with the Imagopole, recently identified, for the first time in viral research, "biofilm" like structures, formed by the HTLV-1 retrovirus on the surface of infected cells. These are aggregates of viruses embedded in a carbohydrate-rich structure containing cell-secreted extracellular matrix, whose synthesis is controlled by the virus.

    The HTLV-1 virus (human T-cell leukemia virus type 1) was the first human retrovirus to be isolated, in 1980, three years prior to the discovery of HIV, the retrovirus that causes AIDS. It infects 15 to 20 million people worldwide and causes various diseases, ranging from adult T-cell leukemia/lymphoma to forms of neuromyelopathy (tropical spastic paraparesis) or other chronic inflammatory syndromes, such as infectious dermatitis, uveitis and myositis. Thedissemination of HTLV-1 was known to require infected cells and cell-cell contacts, but the transmission mechanism itself was still a mystery.

    In the biofilm -- an effective protective and adhesive barrier -- HTLV-1 is far more easily transmitted than in its free, isolated state. By removing the viral biofilm from the surface of the infected cells, researchers achieved an 80% reduction in infection rates, thus underlining the importance of this transmission mode for HTLV-1.

    In bacteria, the existence of biofilms has been known for many years. They form the dental plaque on the enamel surface of teeth and are also found in industrial systems and in our ownintestinal flora . When they colonize medical implants, such as prosthesis or catheters, they can cause repeated infection. For these reasons, bacterial biofilms have been the focus of intensive research in the aim to limit their development and render them responsive to anti-bacterial treatment.

    Scientists are currently seeking to characterize the mechanisms of viral biofilm generation, and to determine whether viruses other than HTLV-1 form this kind of structure. For viruses forming biofilms, it would be useful to define new anti-viral therapeutic strategies, which would target, not only the virus itself, but the formation of these viral biofilms.

    http://www.sciencedaily.com/releases/2010/02/100205115946.htm
     

See more popular forum discussions.

Share This Page